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Introduction

More genetic and psychosocial risk factors in the US

We highlight the severity and high incidence of childhood onset
bipolar disorder in the United States (US) in order to help generate
changes in clinical and public health approaches to this problem. We
outline the scope of the problem of early onset bipolar disorder in the
US and suggest ways of intervening earlier and more effectively.

The question immediately arises as to why there should be more
childhood onsets in the US than in Europe [9,14,15]. There appears to
be a greater amount of both genetic and psychosocial vulnerability.
Compared to those from Europe, patients from the US have greater
genetic loading from their parents for bipolar disorder as well as many
other psychiatric conditions. They also have more psychosocial
vulnerability, both in childhood with more verbal, physical, and sexual
abuse and in the year prior to the onset of their illness with multiple
stressors and loss of social support [13]. Perhaps because of these two
factors, studies of high risk offspring of a parent with bipolar illness in
the US is associated with an earlier onset and higher incidence of
bipolar spectrum disorders than similar studies conducted in Europe
or Canada [9].

Background
Childhood onsets are common in the United States
Childhood onset bipolar disorder as it is currently treated in the
United Stated carries a poor prognosis in the short term based on
prospective follow-up studies of clinical samples [1-4] and into
adulthood based on retrospective studies in adults [5,6]. This is a
problem of enormous proportions given the several percent incidence
of the illness in adolescents in the US [7,8] and the findings that twothirds of all adult bipolar illness had it onset in childhood and
adolescence (before age 19) and more than a quarter of the illness
began in childhood (prior to age 13) [5,9]. Those with childhood onset
do much more poorly than those with adult onsets.

Treatment is often delayed and inadequate
Some 20 years ago, the delay from the onset of first episode of
mania or depression to first treatment averaged more that 15 years for
childhood onset and more than 10 years for adolescent onset [6]. The
duration of delay to first treatment is an independent predictor of poor
outcome in adulthood and associated more time and severity of
clinician-rated depression [10]. While the delays to first treatment may
be shorter currently, they are still often substantial, and treatment over
an 8 year period of follow up in 37% of youngsters was inappropriate
as it never involved any of those that are concensus recommended,
such as atypicals, anticonvulsant mood stabilizers, and lithium [11].

Bipolar disorder is more severe in the US compared to
Europe
The consequences of early onset bipolar disorder and treatment
delay appear to last a life time as the illness is more severe and complex
in the US than in the Netherlands and Germany (abbreviated here for
convenience as Europe) [12]. In addition to early onset, adult
outpatients with bipolar disorder in the US have significantly more
anxiety, alcohol, and substance abuse comorbidity, more episodes and
rapid cycling, more medical comorbidities, and more treatment
nonresponsiveness than those in Europe [13].
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Greater sensitization effects in the US than in Europe
Thus, children, adolescents, and adults with bipolar illness from the
US carry a greater burden of stressors, manic and depressive episodes,
and substance abuse than their European colleagues. The recurrence of
stressors, episodes, and substance abuse is each associated with
sensitization effects (increased responsivity upon repetition) as well as
cross sensitization to the others, each of which further drives illness
progression in an adverse direction. Sensitization to stressors,
episodes, and substance abuse likely involves epigenetic mechanisms
leaving the DNA of patients from the US carrying more permanent
genetic sequence alterations inherited from their parents, as well as
accumulating epigenetic marks based on environmental experience of
stressors, episodes, and substance use [16-18]. It is likely that both
mechanisms will carry vulnerablitity to psychiatric illness into the next
generation, not only via conventional genetic transmission, but
possibly via transgenerational epigenetic transmission which is now
increasingly recognized for parental exposure to stressors and
substance abuse [19-22].

Clinical Implications
Potential treatment approaches
Given this extremely adverse set of circumstances for great numbers
of children in the US with bipolar disorder which will likely extend
throughout their life and even into their offspring in the next
generation, what kinds of interventions might be considered to help
ameliorate this situation? Miklowitz et al [23] have found that family
focused therapy (FFT) is effective in reducing symptoms in children at
high risk because of a first degree relative with bipolar and the
presence of an anxiety, depressive, or BP NOS disorder. Improving
family communication and problem solving skills and reducing family
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discord may be a critical first step in providing a supportive
environment for the child with prodromal or full-blown illness. This
might even be considered in children at very high risk by virtue of
mood disorders in both the parental and grandparental generations
[24,25]. A focus on healthy habits such as diet and exercise may also be
helpful in preventing obesity and inflammation which often
accompany childhood onset mood disorders. Omega 3 fatty acids and
vitamin D3 supplementation might also be considered.
In those with a full syndrome of BP-NOS, BP II, or BP I disorder,
pharmacotherapy as well as psychotherapy should be considered as BP
I and II can take some 9 months on average to stabilize and BP-NOS
often twice as long [1]. Treating BP-NOS is of major import as
Birmaher et al. [1] has found that some 40% of children with BP-NOS
convert to a BP I or II diagnosis after several years of follow up. Based
on the data of Geller et al [26] on the superiority of risperidone over
lithium and valproate, use of a well-tolerated atypical as an adjunct to
a mood stabilizer may be a necessary combination in a large number
of children. In those with residual anxiety and depression, and
particularly if there is comorbid substance abuse (including marijuana,
alcohol, cocaine or heroin), augmentation with N-acetylcysteine
(NAC) may also be useful [18].

Better outcomes with specialty care and education
In those with a first manic episode, the best course of treatment is
now very clear. Kessing et al. [27] randomized those with a first
hospitalization for mania to two years of either a specialty clinic or to
treatment as usual (TAU) in the community. The specialty clinic was
vastly superior to TAU not only for reducing rehospitalization for a
new episode, but also for enhancing compliance and patient
satisfaction. Remarkably, when all patients returned to TAU after the
end of the 2 years, the group previously given the specialty clinic
treatment continued to do exceedingly well over the next 4 years, while
the TAU continued to show increasing relapses such that the
differences between the two original groups not only persisted but
increased in magnitude. The specialty clinic offered an array of
services including: an initial adaptation period post hospitalization,
psychoeducation about the illness and medication management,
cognitive behavior therapy, development of a good monitoring system
to catch early evidence of symptom breakthrough and rehearsal of
procedures to follow should symptoms emerge.
These data cap off an already robust literature that psychoeducation
has lasting benefits [28,29] and cognitive behavioral therapy is
especially helpful early in the course of illness, but not after dozens of
episodes have occurred. Thus, it is clear that special combined
treatment efforts, including education, therapy, and medications are
required to help achieve a good long term treatment outcome.
Otherwise, prospective follow up studies of children and retrospective
studies of adults indicate that extremely adverse outcomes await a
large proportion of children as they are currently being treated in the
US.

members, and the patients themselves are all part of an integrated
team to deliver optimum care to a person with a life-threatening illness
that requires precise monitoring and management in a youngster who
is ill prepared for such a role which is absolutely foreign to his selfconcept and world view. However, the evidence is in that such careful
comprehensive team management now results in decades of enhanced
quality of life, with a great delay in the onset of complications that
used to be all-too-frequent such as blindness, kidney and heart failure,
and loss of limbs to amputation because of peripheral vascular disease.
While we do not have the unequivocal and long term evidence that
equivalent results would be achieved in the treatment of child and
adolescent onset bipolar disorder, the initial data of Kessing et al. [27]
are highly suggestive that this would be the case, and it is hard to
imagine that such a multimodal approach to one of the most complex
and pleiomorphic illnesses in all of medicine would not also yield
positive results. Patients, family members, advocacy groups, clinicians,
and investigators must all insist that such an integrated multimodal
approach become the standard of care and reimbursed by insurance
companies in the same fashion as if it were childhood onset diabetes or
cancer. Until such a day arrives, clinicians must strive to create
enhanced specialty treatment program for each individual patient in
hope of moderating an otherwise potentially devastating and lethal
disorder.
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